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Abstract
Background: Radiation exposure due to the detonation of an improvised nuclear device remains a major security
concern. Radiation from such a device involves a combination of photons and neutrons. Although photons will make
the greater contribution to the total dose, neutrons will certainly have an impact on the severity of the exposure as
they have high relative biological effectiveness.
Results: We investigated the gene expression signatures in the blood of mice exposed to 3 Gy x-rays, 0.75 Gy of
neutrons, or to mixed field photon/neutron with the neutron fraction contributing 5, 15%, or 25% of a total 3 Gy
radiation dose. Gene ontology and pathway analysis revealed that genes involved in protein ubiquitination pathways
were significantly overrepresented in all radiation doses and qualities. On the other hand, eukaryotic initiation factor 2
(EIF2) signaling pathway was identified as one of the top 10 ranked canonical pathways in neutron, but not pure x-ray,
exposures. In addition, the related mTOR and regulation of EIF4/p70S6K pathways were also significantly underrepresented
in the exposures with a neutron component, but not in x-ray radiation. The majority of the changed genes in these
pathways belonged to the ribosome biogenesis and translation machinery and included several translation initiation
factors (e.g. Eif2ak4, Eif3f), as well as 40S and 60S ribosomal subunits (e.g. Rsp19, Rpl19, Rpl27). Many of the differentially
downregulated ribosomal genes (e.g. RPS19, RPS28) have been causally associated with human bone marrow failure
syndromes and hematologic malignancies. We also observed downregulation of transfer RNA processes, in the
neutron-only exposure (p < 0.005). Ingenuity Pathway Analysis (p < 0.05) of differentially expressed genes predicted
significantly suppressed activity of the upstream regulators c-Myc and Mycn, transcription factors known to control
ribosome biogenesis.
Conclusions: We describe the gene expression profile of mouse blood following exposure to mixed field neutron/
photon irradiation. We have discovered that pathways related to protein translation are significantly underrepresented
in the exposures containing a neutron component. Our results highlight the significance of neutron exposures that
even the smallest percentage can have profound biological effects that will affect medical management and treatment
decisions in case of a radiological emergency.
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Background
Radiation exposure due to the detonation of an impro-
vised nuclear device poses a growing threat to human
health. In such a scenario, large populations will be ex-
posed to various doses of radiation. A number of fatal-
ities will occur immediately after the incident, whereas
an even larger number of individuals will experience
long-term effects such as higher incidence of cancer, in-
fections and other diseases. However, many people at a
distance from the directly affected area will also receive
radiation that poses no immediate health risk. The goal
of radiation biodosimetry is to quickly and accurately
evaluate radiation dose as a means to assess radiological
injury. A wide variety of radiation biodosimetry methods
has been developed, ranging from cytogenetic assays [1]
to the more recently proposed miRNA [2], metabolo-
mics [3], and gene expression analyses. Unbiased tran-
scriptomic profiling has been used to assess individual
exposure to radiation. We and others have focused on
peripheral blood cells for the development of transcrip-
tomic approaches. Global gene expression in blood from
mice exposed to photons (x-rays, γ-rays) has shown that
gene expression changes with radiation dose, time, and
dose rate [4–6]. Although radiation quality is expected
to play an important role in driving gene expression, and
different signaling pathways may be triggered in re-
sponse to the different types of irradiation, a limited
number of such studies have been performed. For ex-
ample, a small number of studies have focused on com-
paring gene expression profiles in various tissues
between photon and heavy ions or α-particles, which
could be relevant to a radiological dispersal device. De-
pending on the cell type, similar or distinct gene expres-
sion profiles have been described [7–9].
The detonation of an improvised nuclear device could
expose individuals to a mixture of photon and neutron ir-
radiation. Although most of the radiation dose will come
from photons, a small part of it will be due to neutrons;
however, neutron’s potential of radiological injury will be
disproportionally large, since neutrons have high relative
biological effectiveness (RBE), as they are able to generate
DNA damage that is irreparable or difficult to repair [10].
We previously compared the gene expression signa-
tures in blood of mice exposed separately to either
x-rays or neutrons at 1 and 7 days post-irradiation [11].
Our analysis showed differential gene expression effects
of neutrons versus photons. Gene ontology analysis re-
vealed that genes involved in nucleic acid metabolism
processes were downregulated in neutron-irradiated
mice, whereas genes involved in lipid metabolism were
upregulated in x-ray irradiated animals. Cell cycle pro-
cesses were significant among down-regulated genes at
day 1, but among up-regulated genes at day 7 after ex-
posure to either neutron or x-rays.
There have been a limited number of publications de-
scribing the effect of mixed neutron/photon field irradi-
ation on the survival of various strains of mice and
non-human primates [12–17]. In these studies the neu-
tron component ranges from 50 to 70% of the total radi-
ation dose, somewhat higher than the proportion of
neutron dose expected in an IND. These studies have
shown that exposure to neutron/photon irradiation results
in increased defects in T cell populations, greater suscepti-
bility to bacterial infections, and reduced overall survival
compared with animals irradiated with pure photons.
In the present study, we analyzed transcriptomic
changes over a range of mixed neutron/photon radiation
doses with the neutron component contributing 5, 15,
25%, of the total dose of 3 Gy. For comparison, we also
included mice exposed to 3 Gy of pure x-rays or 0.75 Gy
neutron radiations (equivalent to the neutron compo-
nent in the 83% neutron exposure). To mimic the radi-
ation conditions of an IND detonation, we used the
broad-spectrum neutron irradiator at the Columbia Uni-
versity Radiological Research Accelerator Facility
(RARAF) that is capable of generating neutrons with an
energy spectrum mirroring that produced at 1–1.5 km
from the epicenter of the Hiroshima blast [18, 19]. A
small percentage of photons (~ 17%) contributes to total
radiation dose generated by the neutron source [19].
To our knowledge this is the first description of the
gene expression patterns in mouse peripheral blood after
a mixed-field radiation exposure. Our ultimate goal is to
investigate whether gene expression signatures can ac-




All animal experiments were conducted in accordance
with applicable federal and state guidelines and were ap-
proved by the Columbia University Institutional Animal
Care and Use Committee (IACUC) (approval number
AC-AAAG4356). Male C57BL/6 mice were received
from Charles River Laboratories (Frederick, MD) and
quarantined for 2 weeks before irradiation at 8–10 weeks
of age. Six mice were used for each treatment and sacri-
ficed 7 days after treatment.
Mice were either sham-irradiated or exposed to x-ray,
neutron or mixed field neutron/x-ray radiation as de-
tailed in Table 1. The neutron source delivers a small
percentage of photons, as well. Therefore the maximum
achievable dose of neutrons is approximately 83%. Neu-
tron irradiations were performed using the
accelerator-based IND-spectrum neutron source [19] at
the Radiological Research Accelerator Facility (RARAF).
The characteristics of the neutron source and the mouse
exposure protocol have been detailed previously [11].
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For x-ray irradiation, mice were exposed to various
doses of x-rays from a Westinghouse Coronado ortho-
voltage x-ray machine operating at 250 kVp and 15 mA
with a 0.5 mm Cu + 1 mm Al filter as described previ-
ously [11]. After dose administration, mice were housed
in micro-isolator cages until the time of sacrifice by car-
bon dioxide asphyxiation followed by cervical
dislocation.
Blood collection and RNA isolation
Blood was collected by cardiac puncture at the time of
euthanasia at day 7 post-irradiation. Each sample (~
0.4 ml blood) was added to a 15 ml centrifuge tube that
contained 1.6 ml of PAXgene Blood RNA stabilization
and lysis solution (PreAnalytix GmBH, catalog #
762165) and mixed thoroughly, while a small amount of
blood was added to tubes containing EDTA as
anti-coagulant for blood count using a Genesis
hematology system (Oxford Science). After collection
was complete, blood was mixed gently but thoroughly
and the tubes were incubated at -20 °C for 2 days. Blood
samples were allowed to reach room temperature for 2 h
before proceeding to RNA isolation. RNA was purified
following the PAXgene RNA kit recommendations with
on-column DNase I treatment. Excess globin RNA was
reduced using the Ambion GLOBINclear-mouse/rat kit
(Thermofisher). RNA yields were quantified using the
NanoDrop ND1000 spectrophotometer (Thermofisher)
and RNA quality was checked by the 2100 Bioanalyzer
(Agilent). High quality RNA with an RNA integrity
number of at least 7.0 was used for microarray
hybridization.
Microarray hybridization and data analysis
Cyanine-3 labeled cRNA was prepared using the
One-Color Low Input Quick Amp Labeling kit (Agilent).
Dye incorporation and cRNA yield were measured with
a NanoDrop ND1000 spectrophotometer (Thermo-
fisher). Labeled cRNA was fragmented and hybridized to
Agilent Mouse Gene Expression 4x44K v2 Microarray
Kit (G4846A). Slides were scanned with the Agilent
DNA microarray scanner (G2505B) and the images were
analyzed with Feature Extraction software (Agilent)
using default parameters for background correction and
flagging non-uniform features.
Background-corrected hybridization intensities were
imported into BRB-ArrayTools, version 4.5.0,
log2-transformed and median normalized. Non-uniform
outliers or features not significantly above background
intensity in 25% or more of the hybridizations were fil-
tered out. In addition, a minimum 1.5-fold change in at
least 20% of the hybridizations was set as a requirement.
Furthermore, probes were averaged to one probe per
gene and duplicate features were reduced by selecting
the one with maximum signal intensity. A final set of
14,243 genes that passed the filtering criteria was used
in subsequent analyses. The microarray data is available
through the Gene Expression Omnibus with accession
number GSE113509.
Class comparison was conducted in BRB-ArrayTools
to identify genes differentially expressed (p < 0.001) be-
tween radiation exposed samples and time-matched un-
irradiated controls using a random variance t-test [20].
Genes with p-values less than 0.001 were considered sta-
tistically significant. The false discovery rate (FDR) was
estimated for each gene by the method of Benjamini and
Hochberg [21], to control for false positives. All genes
used in this analysis had a FDR of less than 0.05.
Hierarchical clustering of microarray gene expression
data was performed with the Dynamic Heatmap Viewer
of the BRB-ArrayTools software using a one minus cor-
relation metric and average linkage.
Gene ontology analysis
Lists of genes that were either significantly overex-
pressed or underexpressed compared with controls were
analyzed using the Ingenuity Pathway Analysis (IPA)
core pathway and upstream regulator analysis (Qiagen
Ingenuity Systems). Furthermore, the list of differentially
expressed genes was also analyzed using Protein ANa-
lysis THrough Evolutionary Relationships (PANTHER),
version 11 [22]. Benjamini corrected p values of < 0.05
were considered significant.
Quantitative RT-PCR
cDNA was prepared from total globin-cleared RNA using
the High-Capacity cDNA Archive kit (Thermofisher). Quan-
titative real-time PCR (qRT-PCR) was performed for six
genes using pre-designed validated Taqman assays (Thermo-
fisher). These genes were Crip2 (Mm00517877_m1), Chst3
(Mm00489736_m1), Add3 (Mm00507934_m1), Eif3f
(Mm00517953_m1), Rpl26 (Mm02343715_g1), Rpl27
(Mm01245874_g1), Rps17 (Mm01314921_g1), Rps19
(Mm01611010_g1), and c-Myc (Mm00487804_m1). A
β-actin assay (Mm00607939_s1) was also performed along-
side as control. The gene expression validation experiments
were conducted with 20 ng cDNA using Universal PCR











0 0 3.00 3.00 0%
0.15 0.03 2.82 3.00 5%
0.45 0.08 2.47 3.00 15%
0.75 0.13 2.12 3.00 25%
0.75 0.13 0 0.75 83%
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Master Mix (Thermofisher) in an ABI 7900 Real Time PCR
system. After an initial activation at 50 °C for 2 min and 95 °
C for 10 min, the PCR reaction was performed by 40 cycles
of 95 °C for 15 s and 60 °C for 60 s. Relative fold-induction
was calculated by the 2-ΔΔCT method [23], using SDS ver-




We recently described the gene expression profiles of
mouse blood cells following either x-ray or neutron ir-
radiation and analyzed them 1 and 7 days
post-irradiation. In that report, we found that neutron
radiation results in mainly distinct gene expression pat-
terns compared with x-ray irradiation [11].
In the current study, we investigated whether we can
identify the neutron component after a mixed field
x-ray/neutron exposure, by analyzing gene expression
signatures. Thus, mice were either sham-irradiated or
exposed to 3 Gy of mixed neutron/x-ray exposures that
contained 5, 15, and 25% of neutron component (Table
1). For comparison, mice were also exposed to 3 Gy
x-rays or 0.75 Gy of neutron irradiation (equivalent to
the neutron component in the 83% neutron exposure).
All animals remained in apparent good health, with no
adverse events noted during the course of the study.
Global gene expression was measured in the blood of
mice sacrificed 7 days post-irradiation using Agilent
Whole Mouse Genome Microarrays. Class comparison
using BRB-ArrayTools identified a total of 3850, 3788,
4701, 2859, and 5707 genes differentially expressed (p <
0.001, false discovery rate (FDR) < 5%) between unirradi-
ated controls and x-ray, 5, 15, 25% mixed field x-ray/
neutron, and 83% neutron exposed samples, respectively
(Table 2 and Additional file 1). Following exposures, the
majority of the genes were down-regulated. In our previ-
ous study [11], we had exposed mice to x-ray or neutron
irradiation and had identified a number of genes, includ-
ing Fzr1, Ube2c, and Ccna2 that were upregulated at day
7 post-irradiation. We confirmed in the present study
that these genes were indeed among the list of
upregulated genes in the 3 Gy x-ray and 0.75 Gy neu-
tron exposures. Among the exposures that contained a
neutron component, 1774 significantly differentially
expressed genes were identified (Fig. 1a). Of these genes
376 were uniquely differentially expressed only in neu-
tron, but not in x-rays (Fig. 1b). Unique genes for each
particular exposure were also identified (Fig. 1c). Not
surprisingly, few genes were unique to the 5, 15, and
25% exposures. On the other hand, approximately one
third of all differentially expressed genes in the 83% neu-
tron exposure were unique to that exposure. The overall
number of genes responding to the 25% neutron/x-ray
exposure was significantly lower than other percentages,
reflecting mainly the lower number of downregulated
genes, although the number of the upregulated genes
was comparable. A dose-response effect was not evident
in the majority of differentially exposed genes in the
neutron exposures. Instead, differentially upregulated
genes showed a progressive increase in the fold-change
that peaked at 15% neutron/photon. Likewise, downreg-
ulated genes showed the maximum fold-change again at
15% neutron/photon.
Gene ontology analysis
We used Ingenuity Pathway Analysis (IPA) to identify
the most significantly enriched molecular functions. Bio-
logical processes and pathways over-represented among
differentially expressed genes with a Benjamini-corrected
p-value of less than 0.05 were considered significant.
The top ten canonical pathways based on the signifi-
cance of the enrichment (p-value) are shown in Fig. 2.
Canonical pathways pertaining to B- and T-cell immune
response were uniformly underrepresented in all radi-
ation exposures (Fig. 2a). In contrast, the “EIF2 signal-
ing” pathway was significantly underrepresented only in
the exposures that included a neutron component (Fig.
2a and Additional file 2). If the additional criterion of
fold-change ±2 was applied to the IPA analysis, the
“EIF2 signaling” pathway was among the significantly
enriched pathways in the mixed-field and 83% neutron
exposure, but interestingly not in the pure x-ray expos-
ure (Additional file 3 Figure S1), thus underlining the ro-
bustness of the study. In addition, the related “mTOR
signaling” and “regulation of eIF4/p70S6K1 signaling”
pathways were also significantly underrepresented in the
15 and 83% exposures. A summary of –log (p-value) is
shown (Fig. 2b).
The PANTHER gene ontology tool was used as an
additional method for evaluating functional signifi-
cance of the radiation-induced gene profiles. Analyz-
ing the results (p < 0.005; Additional file 4) confirmed
that among top pathways significantly underrepre-
sented in the neutron exposures were those related to
EIF2 signaling (Table 3).
Table 2 Differentially expressed genes
neutron up down total %up %down
0% 1373 2477 3850 35.7 64.3
5% 829 2959 3788 21.9 78.1
15% 1417 3284 4701 30.1 69.9
25% 1052 1807 2859 36.8 63.2
83% 1390 4317 5707 24.4 75.6
Significantly differentially expressed genes in mouse blood after x-ray,
neutron, or mixed field x-ray/neutron treatment relative to unirradiated
controls (p < 0.001). Percent of upregulated (up) and downregulated (down)
genes are shown
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Examining the list of differentially expressed genes in
the EIF2 signaling pathway (Additional file 5) we noticed
that several genes coding for eukaryotic initiation factors
(eIFs) were mostly downregulated after irradiation. Inter-
estingly, some eIFs (Eif2b4, Eif2s3x, and Eif3k) were dif-
ferentially expressed after x-ray irradiation, whereas
others (Eif2ak4, Eif3f, Eif3l) were differentially expressed
after radiation that contained a neutron component
(Additional file 5). Furthermore, this pathway included a
large number of ribosomal protein (RP)-encoding genes
that were downregulated in all radiation types. However,
a group of 15 RP genes (~ 50% of all differentially regu-
lated RP genes in this pathway) were specifically down-
regulated in the neutron component exposures, but not
x-rays. A heatmap was constructed to visualize this ob-
servation (Fig. 3). Rps25 was the only ribosomal gene
that was differentially upregulated by x-rays, but not
neutron exposure. The RP gene downregulation was evi-
dent even at 5% neutron and the fold-change did not
vary appreciably with increasing percentage of neutron
contribution. Loss-of-function, by deletion or mutation,
of genes that code for ribosomal proteins are known as
ribosomopathies and are causally associated with various
human diseases, most prominent of which is the
Diamond-Blackfan anemia. We queried the list of the
neutron downregulated RP genes and discovered that
many of these genes have been associated with the
Diamond-Blackfan syndrome (Table 4).
Further analysis revealed that, in addition to the EIF2
pathway, biological processes related to tRNA were also sig-
nificantly underrepresented in the neutron exposures,
mainly in the 83% neutron exposure (Table 5). The list of
tRNA-related biological processes included a number of
aminoacyl-tRNA ligases (valine, threonine, arginine), en-
zymes responsible for charging amino acids to cognate
tRNA molecules, as well as tRNA methyltranferases, essen-
tial enzymes for tRNA maturation. tRNA binding process
(GO:0000049) showed progressively lower p-values with
Fig. 1 Differentially expressed genes. a Venn diagram showing overlap patterns of genes that are differentially expressed in response to 0.75 Gy
neutron (83%), or 3 Gy mixed-field neutron/x-ray (5, 15, 25%). b Venn diagram comparing differentially expressed genes in x-rays (x-ray) versus
neutron or neutron/x-ray (neutron) exposures. c Table showing absolute number and percent of differentially expressed genes (DEGs) unique to
each treatment
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Fig. 2 a Ingenuity Pathway Analysis (IPA) top 10 canonical pathways for each treatment (p < 0.001). The most statistically significant canonical
pathways identified in the neutron exposure are listed according to their p value (−log; orange line). Blue bars: negative z-score; orange bars:
positive z-score; gray bars: no activity pattern available. The orange squares represent the ratio of the number of differentially expressed genes
found in each pathway over the total number of genes in that pathway. b IPA on EIF2-related differentially expressed genes plotted according
their p-value (−log)
Table 3 mRNA Translation-related biological processes in response to radiation as identified by PANTHER analysis (p < 0.005)
Term 0% 5% 15% 25% 83%
eukaryotic initiation factor 4E binding (GO:0008190) 3.09E-02 3.79E-02 6.40E-03
translation initiation factor binding (GO:0031369) 2.63E-03 1.86E-03 1.02E-05
eukaryotic initiation factor eIF2 binding (GO:0071074) 1.60E-02 3.67E-02
translation initiation factor activity (GO:0003743) 2.99E-02 6.78E-04 1.75E-02 2.01E-06
translation elongation factor activity (GO:0003746) 2.06E-02
translation termination factor activity (GO:0008079) 3.92E-02
translation release factor activity (GO:0003747) 3.92E-02
Significantly enriched biological processes among genes downregulated in response to radiation. Benjamini-corrected p values are shown for each
radiation exposure
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increasing contribution of neutrons, while this process did
not attain significance after pure x-ray irradiation. Similarly,
“translation factor activity, RNA binding” (GO:0008135), as
well as “catalytic activity, acting on a tRNA” (GO:0140101)
processes showed the same lower p-value with higher neu-
tron percentage. An exception to this trend was the 25%
exposure.
Finally, PANTHER analysis revealed that processes re-
lated to protein ubiquitination were highly significant
among upregulated genes in all radiation doses and
qualities (Additional file 6 Table S1).
We also searched for upstream regulators of differen-
tially regulated genes by using the upstream regulator
analysis tool in IPA. This feature connects the upstream
regulators with downstream functions to generate regu-
lator effects hypotheses with predicted activation of up-
stream transcription regulators. We used the default
z-score > 2 or z-score < − 2 as the significance cutoff for
our analysis. The top candidate regulators are shown in
Fig. 4 and Additional file 7. Most of the predicted up-
stream regulators showed similar z-scores across radi-
ation treatments. However, Cst5 (Cystatin D) showed a
progressively larger (positive) z-score with the percent-
age of the neutron component. Exception was the 25%
neutron/x-ray exposure that z-score did not attain statis-
tical significance. A second candidate, Trim24 (tripartite
motif-containing 24; Tif1) was a positive regulator of
x-rays and x-ray/lower percentage of neutron combin-
ation, but not 83% neutrons. In contrast, type I
Interferon family genes, Ifnα, Ifnαβ and Ifnar (interferon
(alpha and beta) receptor 1), important regulators of in-
nate antiviral and antibacterial immunity [24], were pre-
dicted to be negative regulators in the exposures that
contained pure photons or low percentage (5, 15%) neu-
trons, but not 83% neutrons. Finally, we searched for up-
stream regulators that function as transcription factors
and identified c-Myc and Mycn as two negative regula-
tors that displayed progressively more negative z-scores
with increasing percentage of neutron component. The
z-scores for c-Myc were − 2.0 and − 5.1 for pure x-rays
and 83% neutrons, respectively, whereas for Mycn were
− 1.3 (x-rays; not significant) and − 4.4 (83% neutrons).
Again 25% neutron exposure did not predict c-Myc or
Mycn as upstream regulators. The c-Myc gene itself was
found downregulated in 5, 15, and 83% neutron expos-
ure (p < 0.005) in our microarray data.
Validation of microarray data
We confirmed the expression pattern of some of the dif-
ferentially expressed genes derived from the DNA
microarray experiment, by quantitative real-time PCR
(Fig. 5). We chose genes that changed in all radiation ex-
posures (Crip2, Chst3) or were specific to neutron radi-
ation (Add3, Eif3f, Rpl26, Rpl27, Rps17, Rps19, c-Myc).
Analysis of gene expression of Crip2, Chst3, Add3, Eif3f,
Rpl26, Rpl27, Rps17, Rps19, and c-Myc by qRT-PCR con-
firmed that these genes are regulated by irradiation. As
mentioned above, differentially expressed genes showed
Fig. 3 Heatmap illustrating relative gene expression of ribosomal genes among the differentially expressed genes (p < 0.001) at various radiation
exposures. Red indicates high expression; green indicates low expression, as indicated in the color key. Each row represents one gene and each
column represents an individual mouse
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a progressive increase in the fold-change that peaked at
15% neutron/photon. Thus, we validated Crip2, Add3,
and Chst3 by qPCR as representatives of upregulated
(Crip2) and downregulated (Add3, Chst3) genes to dem-
onstrate that pattern. The rest of the qPCR-validated
genes belong to the “EIF2 signaling” canonical pathway.
The fold-change of these genes in response to radiation
was in good agreement with the fold-change calculated
by the microarray experiment (Additional file 8 Figure
S2). The only exception was the expression of c-Myc in
the 25% neutron samples that appeared to be downregu-
lated by qPCR analysis, whereas DNA microarray ana-
lysis showed no significant downregulation.
Discussion
Previously, we described the transcriptomic profile in
blood from mice exposed separately to neutron or x-ray
radiation and showed that neutron radiation generates a
gene expression profile that is mostly distinct from that
of x-ray radiation [11]. These results suggested that dif-
ferences in gene signatures between x-ray and neutron
exposures could potentially be exploited for the purpose
of radiation biodosimetry. However, in a real-life situ-
ation, the detonation of an IND is expected to produce a
mixture of x-rays and neutrons. Although the fraction of
neutrons in such a situation is not expected to exceed
25–30% [25], its biological and medical impact is pre-
dicted to be substantial due to the fact that neutron radi-
ation has high relative biological effectiveness.
Therefore, in this study, we examined the gene expres-
sion profile in mouse blood exposed to mixed field neu-
tron/x-ray radiation. Gene expression profiles in mice
Table 4 Loss-of-function ribosomal protein (RP) genes related
to Diamond-Blackfan anemia and RP genes downregulated (DN)
after neutron exposure
Diamond-Blackfan anemia























(2)Only in 15 and 83% neutron exposures
Table 5 tRNA-related biological processes in response to radiation as identified by PANTHER analysis (p < 0.005)
Term 0% 5% 15% 25% 83%
ligase activity, forming aminoacyl-tRNA and related compounds (GO:0016876) 3.14E-02 2.84E-05
aminoacyl-tRNA ligase activity (GO:0004812) 3.14E-02 2.84E-05
translation factor activity, RNA binding (GO:0008135) 1.62E-02 8.08E-04 8.91E-08
tRNA binding (GO:0000049) 2.99E-02 9.98E-03 6.82E-03 1.99E-07
catalytic activity, acting on a tRNA (GO:0140101) 6.71E-04 4.83E-02 4.88E-10
tRNA (guanine-N1-)-methyltransferase activity (GO:0009019) 1.88E-02 3.67E-02
tRNA-specific ribonuclease activity (GO:0004549) 2.56E-02 9.52E-03
tRNA (guanine) methyltransferase activity (GO:0016423) 3.64E-02 2.87E-03
aminoacyl-tRNA editing activity (GO:0002161) 2.62E-02 1.77E-03
valine-tRNA ligase activity (GO:0004832) 1.76E-02
threonine-tRNA ligase activity (GO:0004829) 1.76E-02
glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity (GO:0050567) 1.76E-02
tRNA methyltransferase activity (GO:0008175) 3.33E-02
arginine-tRNA ligase activity (GO:0004814) 3.67E-02
tRNA dihydrouridine synthase activity (GO:0017150) 3.67E-02
Significantly enriched biological processes among genes downregulated in response to radiation. Benjamini-corrected p values are shown
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exposed to 3 Gy x-rays or 0.75 Gy neutrons were similar
to our previous study [11]. Genes, including Ccna2,
Ube2c, and Fzr1 that had previously been found to be
upregulated at day 7 post-irradiation were also upregu-
lated in the current study, thus confirming the reprodu-
cibility of our results. Likewise, In agreement with our
current results, biological processes related to protein
translation and DNA/RNA metabolism were also identi-
fied in our previous study following 83% neutron, but
not pure x-ray exposure [11]. In particular, “Translation”
(GO:0006412; p value 4.55E-11) and related pathways
(GO:0006418; p = 0.026 and GO:0051084; p = 0.022)
were significantly enriched in 83% neutrons but not in
x-rays at day 7 post-irradiation. Furthermore, DNA/
RNA metabolism processes, including tRNA processes,
were identified predominantly in the 83% neutron expo-
sures as well. For example, GO:0006399 (tRNA metabol-
ism) was found significantly enriched among
downregulated genes exposed to neutrons in both the
previous (p = 1.37E-06), as well as the current study (p =
1.43E-08).
The overall number of differentially expressed genes in
the mixed-field exposure was increasing with the per-
centage of the neutron component (Table 2). In contrast,
the number of genes responding to the 25% neutron/
x-ray exposure was significantly lower than the other
percentages, possibly reflecting increased cell death. In-
deed, in response to radiation, the number of white
blood cell count is reduced considerably more in the
25% neutron/photon exposure than in the other expo-
sures. However, to conclusively determine whether the
25% neutron/photon exposure causes the most severe
effect on cell and organismal survival compared with the
other exposures, future studies should focus on long
term time-course survival experiments.
Mice exposed to mixed field irradiation with neutrons
contributing 5, 15%, or 25% of the total exposure dose, as
well as mice exposed to 83% neutrons (the highest achiev-
able percent generated by our neutron source) identified
376 uniquely differentially expressed genes that were not
shared with mice exposed to pure x-rays. However, the
fold-change of these neutron-specific genes was not
dependent on the percent of the neutron component.
The spectrum of biological functions and pathways
within our differentially expressed genes was analyzed by
using both IPA and PANTHER gene ontology analysis
tools. PANTHER analysis showed that ubiquitin
metabolism-related biological processes are commonly
overrepresented among upregulated genes in all radi-
ation exposures. In addition, we identified pathways re-
lated to amino acid and fatty acid oxidation to be among
the significantly underrepresented pathways in the 83%
neutron exposure. This finding is in agreement with re-
cently published metabolomics data that compared
Fig. 4 Potential upstream regulators of differentially expressed
genes by neutron component using Ingenuity pathway upstream
regulator. Top predicted upstream regulators (|z| > 2) are shown. Blue
color represents negative z-scores; orange color represents positive
z-scores as indicated in the color key. c-Myc and Mycn transcription
factors are in bold
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x-rays to neutron radiation and found that neutrons in-
duced a severe metabolic dysregulation, with perturba-
tions predominantly in amino acid metabolism and fatty
acid β-oxidation [26].
IPA (p < 0.001) and PANTHER (p < 0.005) analyses re-
vealed that neutron exposure significantly suppressed pro-
cesses involved in the protein translation machinery. “EIF2
signaling”, and the related pathways “mTOR signaling” and
“regulation of eIF4 and p70S6K signaling” were among the
top 10 significantly underrepresented canonical pathways
in exposures that contained a neutron component. These
processes are known to control protein synthesis by regu-
lating mRNA translation, ribosome biogenesis, and tRNA
loading [27]. mRNA translation is divided into four phases:
initiation, elongation, termination, and recycling [28]. Initi-
ation, the rate-limiting step of translation, is regulated by
signaling pathways such as mTOR and p70S6K that con-
verge on the control of eukaryotic initiation factors. Re-
duced translation driven by impaired ternary complex
formation (eIF2, GTP, Methionine-tRNA) is encountered in
conditions of specific cellular stress, that is, viral infection,
amino acid deprivation, and unfolded protein response.
Examining the list of differentially expressed genes in this
category, we noted that most of the genes were eukaryotic
initiation factors, whereas elongation or termination factors
were not particularly enriched.
The most prominent distinguishing feature between
x-ray and neutron exposures was the downregulation of a
large number of genes that code for ribosomal proteins, in-
cluding a majority of those encoding both the large (Rpl)
and small (Rps) subunits, in the neutron exposures. Inter-
estingly, a group of 15 RP genes was first detected down-
regulated at the 5% exposure, which was the lowest
percentage in the mixed field exposure. Ribosomal proteins
have traditionally been considered as essential but passive
participants of protein synthesis. However, changes in RP
transcript levels have been observed among different cell
and tissue types [29, 30]. Furthermore, loss-of-function mu-
tations of several ribosomal proteins lead to inherited dis-
eases and increased tumor formation, as well as to a
number of specific human disorders called ribosomopa-
thies. Ribosomopathies are characterized by defective ribo-
somal function or production and include the
Shwachman-Diamond syndrome, chromosome 5q-deletion
syndrome, and the Diamond-Blackfan syndrome [31, 32].
These diseases initially present clinical features that can be
Fig. 5 Gene expression measured by qRT-PCR. Expression of nine genes (Crip2, Chst3, Add3, Eif3f, Rpl26, Rpl27, Rps17, Rps19, and c-Myc) shown by
microarray analysis to be differentially expressed relative to controls and normalized to Actb expression. Data represent the mean ± S.E.M. (n = 3)
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attributed to cell proliferation defects and, depending on
the affected tissue, include bone marrow failure, craniofacial
malformations, bacterial infections, and mental and motor
defects [31]. Intriguingly, some of these syndromes have
also been associated with higher incidence of cancer later
in life. In particular, Diamond-Blackfan anemia (DBA) is an
autosomal dominant disorder with symptoms that include
macrocytic anemia, growth retardation, craniofacial and
thumb malformations, anomalies of the heart and genito-
urinary system, and a predisposition to develop AML (acute
myeloid leukemia), as well as solid tumors [31, 33]. DBA is
associated in many cases with loss-of-function of RP genes
(Table 4). The most frequently mutated gene in DBA,
which represents 25% of the cases, is that encoding RPS19
[33]. A mouse model for DBA that contains a
loss-of-function point mutation in the Rps19 gene has
been demonstrated to have a dominant negative effect
[34] and, importantly, mice with Rps19 deficiency develop
bone marrow failure and symptoms like patients with
Diamond-Blackfan anemia [35]. Interestingly, Rps19 is
one of the RP genes downregulated in the neutron or
mixed neutron/photon, but not x-ray, exposed mice. An-
other gene downregulated specifically in irradiation expo-
sures that contain a neutron fraction is Rps28. Human
RPS28 is mutated in DBA [36] and a decrease in transla-
tion of Rps28 mRNA blocks pre-18S ribosomal RNA pro-
cessing, resulting in a reduction in the number of 40S
ribosomal subunits [37]. Rpl19, a gene that is also prefer-
entially downregulated after mixed field irradiation, is an
evolutionarily conserved gene. RPL19 knockdown reduces
growth of human prostate cancer cells both in vitro and
as xenografts [38]. Furthermore, RPL19 has been pro-
posed to be a sensitive predictor of prostate cancer pro-
gression [38, 39]. Among the neutron-regulated RP genes,
Rpsa gene is the only that is differentially downregulated
(~ 3-fold) in 83% neutron, but not lower percentages neu-
tron or pure x-ray exposures. Rpsa mutation causes severe
bacterial infections [40] and the protein can also act as a
nonintegrin cell-surface receptor with high affinity for
laminin with a key role in tumor invasion and metastasis
[41]. Finally, Rps25 was the only ribosomal gene that was
differentially expressed by x-rays but not neutron expos-
ure. Rps25 expression is strongly suppressed in rat liver re-
generation after partial hepatectomy, suggesting that it
may have a role in liver growth [42].
Gene expression profiles of bone marrow mono-
nuclear cells from patients with Shwachman-Diamond
syndrome revealed significant downregulation of RP
genes, including RPS9, RPS20, RPL6, RPL15, RPL23, and
RPL29, or upregulation of RPS27 [43]. However, none of
these genes are differentially expressed in response to ra-
diation in our study. Likewise, Rps14 loss-of-function
that causes the 5q syndrome [43] was not among the dif-
ferentially expressed genes.
Further analysis identified enrichment in tRNA-related
biological processes that included a number of
aminoacyl-tRNA ligase activities (valine, threonine, arginine
tRNA ligases). Aminoacyl-tRNA ligases are responsible for
charging amino acids to cognate tRNA molecules, which is
the essential first step of protein translation. Mutations in
genes encoding aminoacyl-tRNA ligase enzymes have been
implicated in a broad array of human inherited diseases.
The vast majority of these mutations show loss-of-function
effects and impair protein translation [44].
In addition, tRNA methyltransferase activities were un-
derrepresented in the 83% neutron exposure, as well.
tRNAs molecules undergo extensive post-transcriptional
processing to generate the mature functional tRNA spe-
cies that are essential for translation in all organisms.
Among these modifications, methylation reactions are the
most abundant. RNA methyltransferases are a diverse
group of post-transcriptional RNA modification enzymes
responsible for the transfer of a methyl group from a me-
thyl donor, most commonly S adenosylmethionine, to any
of several different locations on a target RNA nucleotide.
Mutations in tRNA methyltransferases have been increas-
ingly associated with human disease [45].
We also inferred the key regulators responsible for tran-
scriptional changes in neutron versus x-ray exposures.
Among the most highly represented upstream regulators
were c-Myc and Mycn. The c-Myc family of transcription
factors includes three highly conserved genes, c-Myc,
Mycn, and Mycl1. c-Myc has an evolutionarily conserved
role in the control of cell size and protein synthesis [46]
and regulates the transcription of a multitude of genes, in-
cluding those involved in proliferation, growth, differenti-
ation, and ribosome biogenesis [47]. Unrestrained
increases in global protein synthesis can lead to tumori-
genesis [48]. An examination of the differentially
expressed genes revealed that c-Myc itself was downregu-
lated in the 83% (p < 0.001), 15% (p < 0.005), and 5% (p <
0.005) neutron or neutron/x-ray exposures, but not in
25% or pure x-ray exposures, even when examined at the
lower p-value. In contrast, qPCR analysis revealed that
c-Myc is downregulated in all neutron-exposed samples.
These observations reveal that c-Myc is significantly af-
fected by neutron irradiation. Future genome wide ana-
lysis should aid in elucidating the mechanistic connection
between c-Myc levels and high-LET (linear energy trans-
fer) irradiation.
In this report we present for the first time the gene ex-
pression profiling in mouse blood exposed to
mixed-filed neutron/x-ray irradiation. We have identified
gene expression changes that suggest neutron exposure
has a marked effect on ribosome biogenesis and mRNA
translation. Furthermore, we show that a number of RP
genes frequently defective in Blackfan-Diamond syn-
drome anemia are downregulated in response to neutron
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or mixed field irradiation, but not pure x-rays. Gene
ontology and pathway analysis revealed that protein ubi-
quitylation pathways are enriched among upregulated
genes in all radiation exposures, whereas EIF2 signaling
and related pathways are enriched predominantly after
neutron or mixed field irradiation. The finding that
genes involved in protein synthesis are downregulated
may reflect the fact that during stress, cells reduce the
rate of protein synthesis, an energy-demanding process,
so that they may better cope with the damage. As neu-
trons are known to cause greater damage in cells than a
comparable dose of photons, it is, perhaps, not surpris-
ing that we find processes involved in mRNA translation
to be underrepresented. We hypothesize that the down-
regulation of RP genes specifically in the neutron expo-
sures reflects the detrimental effect of neutron exposure
to bone marrow. In line with this interpretation, Cary et
al. [12] have shown a decline in bone marrow cellularity
7 days after exposure to mixed field radiation.
Furthermore, our results provide insight into the poten-
tial usefulness of neutron radiation in the treatment of
cancer. Accumulating evidence suggests a regulatory func-
tion for ribosomes in gene expression [49]. Dysregulation
of protein synthesis by altering ribosome function impairs
hematopoietic stem cell function [50] and mediates cancer
or chemotherapeutic cancer resistance. Similar to the data
presented here it was recently shown that some chemo-
therapeutic agents, exemplified by oxaliplatin, act as
anti-cancer drugs not by inducing the DNA damage re-
sponse pathway, but rather by inducing ribosome biogen-
esis stress [51]. In support of this finding, a proteomic
profiling revealed that numerous ribosomal proteins are
dysregulated in response to oxaliplatin treatment in
T-lymphoblastic leukemia-derived cancer cells [52].
In the future, we plan studies to determine the impact
of neutron and mixed field exposures on animal health
and survival in comparison with animals exposed to pho-
tons. Furthermore, we intend to perform mechanistic
studies to assess the genetic and phenotypic consequences
of RP gene downregulation after neutron irradiation. We
anticipate that the preferential downregulation of certain
RP genes after irradiation containing a neutron compo-
nent will change the balance in ribosomal protein com-
position and this may have an impact on the selectivity of
translating subsets of mRNAs involved in specific bio-
logical processes as has been observed before [53]. Gene
expression profiling using polysome-bound mRNA
followed by microarray analysis can aid in identifying
mRNA transcripts differentially expressed in mice specif-
ically exposed to neutron or mixed neutron/x-ray irradi-
ation. We will gain further insight by focusing on the bone
marrow mononuclear cells and hematopoietic stem cells,
two cellular compartments that are the targets of RP gene
defects that impair their function [46, 47].
Conclusions
Our data provide evidence that biological processes re-
lated to mRNA translation are significantly underrepre-
sented following neutron exposure, even at the smallest
neutron percentage (5%). In addition, tRNA processes
are also downregulated in the 83% neutron exposure.
Among the differentially expressed genes, neutron ex-
posure results in the downregulation of multiple riboso-
mal protein genes. In humans, loss of function of many
RP genes and ribosome dysfunction has been associated
with bone-marrow failure syndromes. In fact, many of
the RP genes mutated in Diamond-Blackfan syndrome
are the same as the RP genes downregulated after expos-
ure to neutron irradiation. The observation that these
genes are downregulated by even a 5% neutron compo-
nent in a mixed-field radiation exposure attests to the
established fact that neutrons are able to cause much
more severe DNA damage compared to photons [54]. It
is therefore important for emergency planners to be able
to detect the neutron component in the case of a deton-
ation of an IND.
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